In 2015, Christian Weyer earned $366.03K in total compensation at Fate Therapeutics, primarily from $366.03K salary. Most recently acquired 5,429 shares in Jan 2015. Currently holds stock worth $29.33K. Led Fate Therapeutics as CEO for 3 years.
Compensation History
Annual executive compensation data for Christian Weyer, including salary, bonuses, and stock awards.
Year
2015
Total Compensation
$366.03K
Salary
$366.03K
Bonus
$0.00
Other
$0.00
Salary
$366.03KBoard Justification
The company aims to align CEO compensation with performance metrics related to corporate objectives, including advancement of clinical and preclinical programs and corporate development initiatives.
Bonus
$0.00Board Justification
No non-equity incentive plan compensation was reported for 2015 as Dr. Weyer voluntarily resigned before the end of the year.
Other Compensation
$0.00Board Justification
No other compensation was reported for 2015.
Restricted Stock
Board Justification
No stock awards were reported as vested for 2015.
Performance Metrics
The performance metrics for determining compensation included objectives related to the advancement of clinical and preclinical programs and achievement of corporate development and financing initiatives.
Christian Weyer
Ex-CEO of Fate Therapeutics
Education
M.D. from the University of Ulm, Germany.
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
June 15, 1965 - 60 years ago
CEO of Fate Therapeutics for
3 years 2 months (Sep 2012 - Nov 2015)
Previous Experience
Served as Chief Medical Officer at Amylin Pharmaceuticals.
Other Fate Therapeutics CEOs
Holdings
Track Christian Weyer's stock holdings and portfolio value over time.
Total Stock Sold
$90.32K
$90.32K
10,000 FATE shares
What if they kept their stock?
If Christian Weyer didn't sell their stock, today they would have:
Extra FATE10,000 shares worth $9.64K.
This is -89.33% and $80.68K less than what they got when they sold the stock.
Insider Trading
Christian Weyer's recent stock transactions, purchases, and sales filed with the SEC.
5,429 shares
FATE
Jan 5, 2015
Received
$90.18K
FATE at $9.02/share
Apr 1, 2014
Sale
Rivals
Compare Christian Weyer with competitor CEOs and industry peers.